亿帆医药(002019.SZ)：麻芩消咳颗粒获得新加坡注册批文

智通财经网02-29

亿帆医药(002019.SZ)发布公告，公司全资子公司SciGen Pte.Ltd.(“赛臻公司”)于近日收到新加坡卫生科学局(Health Sciences Authority)(以下简称“HSA”)核准签发的中成药注册批文，批准公司独家医保产品麻芩消咳颗粒在新加坡上市销售。据悉，麻芩消咳颗粒来源于安徽省名老中医的临床经验方，以“麻杏石甘汤”为基础加减而成，上市前已在临床应用多年，清肺化痰，止咳...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2415204543?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-02-29 19:52","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2415204543","market":"fut","top_or_hot":-1,"title":"亿帆医药(002019.SZ)：麻芩消咳颗粒获得新加坡注册批文","media":"智通财经网","content":"<div>\n<p>亿帆医药(002019.SZ)发布公告，公司全资子公司SciGen Pte.Ltd.(“赛臻公司”)于近日收到新加坡卫生科学局(Health Sciences Authority)(以下简称“HSA”)核准签发的中成药注册批文，批准公司独家医保产品麻芩消咳颗粒在新加坡上市销售。据悉，麻芩消咳颗粒来源于安徽省名老中医的临床经验方，以“麻杏石甘汤”为基础加减而成，上市前已在临床应用多年，清肺化痰，止咳...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inaktftc1234432.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>亿帆医药(002019.SZ)：麻芩消咳颗粒获得新加坡注册批文</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n亿帆医药(002019.SZ)：麻芩消咳颗粒获得新加坡注册批文\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-02-29 19:52 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inaktftc1234432.shtml><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>亿帆医药(002019.SZ)发布公告，公司全资子公司SciGen Pte.Ltd.(“赛臻公司”)于近日收到新加坡卫生科学局(Health Sciences Authority)(以下简称“HSA”)核准签发的中成药注册批文，批准公司独家医保产品麻芩消咳颗粒在新加坡上市销售。据悉，麻芩消咳颗粒来源于安徽省名老中医的临床经验方，以“麻杏石甘汤”为基础加减而成，上市前已在临床应用多年，清肺化痰，止咳...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inaktftc1234432.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ES3.SI","symbol_name":"STI ETF","start_time":0,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inaktftc1234432.shtml","article_id":"2415204543","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-29/doc-inaktftc1234432.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2415204543","pubTimestamp":1709207520,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"亿帆医药发布公告，公司全资子公司SciGen Pte.Ltd.于近日收到新加坡卫生科学局核准签发的中成药注册批文，批准公司独家医保产品麻芩消咳颗粒在新加坡上市销售。本次麻芩消咳颗粒获新加坡注册批文，是公司继独家产品复方银花解毒颗粒后的第二个中药核心产品成功实现海外注册，为公司中药产品海外注册积累了宝贵经验，进一步丰富了公司境外产品结构与产品管线。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"ES3.SI":"STI ETF","002019":"亿帆医药","BK0077":"质押式回购","BK6516":"银行与投资服务概念","BK0197":"中小创蓝筹","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","S68.SI":"新加坡交易所","LU0898667661.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD-H","BK6523":"ESG概念","BK6033":"金融交易所和数据","LU0205439572.USD":"富达亚太股息基金","SG9999000343.SGD":"Schroder Singapore Trust A Dis SGD","FSTAS.SI":"富时海峡全股指数","FSTM.SI":"富时海峡中盘指数","SG9999001135.SGD":"United ASEAN Fund SGD","BK0191":"维生素","STI.SI":"富时新加坡海峡指数","BK0070":"员工持股","BK0185":"二线龙头","BK0239":"医药制造","LU0831103253.SGD":"JPMorgan Funds - Asia Pacific Income A (mth) SGD","SG9999016042.SGD":"Schroder Singapore Trust A Acc SGD"},"translate_title":"Yifan Medicine (002019. SZ): Maqin Xiaoke Granules obtained Singapore registration approval","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STI.SI":1,"S68.SI":1,"002019":1,"FSTAS.SI":0.6,"FSTM.SI":0.6,"ES3.SI":0.6},"content_text":"亿帆医药(002019.SZ)发布公告，公司全资子公司SciGen Pte.Ltd.(“赛臻公司”)于近日收到新加坡卫生科学局(Health Sciences Authority)(以下简称“HSA”)核准签发的中成药注册批文，批准公司独家医保产品麻芩消咳颗粒在新加坡上市销售。据悉，麻芩消咳颗粒来源于安徽省名老中医的临床经验方，以“麻杏石甘汤”为基础加减而成，上市前已在临床应用多年，清肺化痰，止咳平喘，预防、治疗皆有效。经过系统的药理毒理研究和临床研究，表明其具有明显的镇咳、祛痰、平喘作用，且无毒副作用。因其为纯中药成分，无药物依赖性及成瘾性，安全性好。该产品于2019年通过谈判首次纳入国家医保目录，2023年调整至常规国家医保目录。本次麻芩消咳颗粒获新加坡注册批文，是公司继独家产品复方银花解毒颗粒后的第二个中药核心产品成功实现海外注册，为公司中药产品海外注册积累了宝贵经验，进一步丰富了公司境外产品结构与产品管线。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2415204543"}